Clinical Trial Update: Immunogenicity Study of an Anti-pneumococcal Vaccination Strategy in Patients With Sickle Cells Disease [Phase 2]

View source ↗

Summary

Phase 2 immunogenicity study evaluating an anti-pneumococcal vaccination strategy in patients with sickle cell disease; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Pneumococcal Infections
• Sickle Cell Disease

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Invasive Pneumococcal Infections, Sickle Cells Disease | Phase 2 | Status: COMPLETED